NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

ECONOMIC ANALYSIS OF HYPERBARIC OXYGEN THERAPY FOR DIABETIC FOOT ULCERS.

Hailey D, Jacobs P, Chuck A; Health Technology Assessment International. Meeting (3rd : 2006 : Adelaide, S. Aust.).

Handb Health Technol Assess. 2006; 3: 4.

Department of Community Health Sciences, University of Calgary, 22 Sinclair Street, Kambah, Canberra

Background: Hyperbaric oxygen therapy (HBOT) has been suggested as an adjunct to standard methods of care for diabetic foot ulcers (DFU). Its use may decrease the risk of infection and lower extremity amputations (LEAs), though available evidence is only of fair quality. As part of a Canadian assessment, we estimated the cost-effectiveness and budget impact of HBOT in this application. Methods: We developed a decision model comparing adjunctive HBOT with standard care alone. The population was a 65 year-old cohort with DFU, the time horizon 12 years and the perspective that of a Ministry of Health. The health states were a healed wound with or without a minor LEA, an unhealed wound with no related surgery and a major LEA. Cost and capacity needs for treating DFU patients in Canada were estimated using prevalence data from the literature and provincial cost and utilization data. Results: The 12-year cost for patients receiving HBOT was C$40,695 compared to C$49,786 for standard care alone. Outcomes were 3.64 QALYs for those receiving HBOT and 3.01 QALYs for controls. Estimated cost to treat all prevalent DFU cases in Canada was C$7.3 million/year over four years. If seven person multiplace HBOT chambers were used, the equivalent of 12.4 machines would be required nationally. Conclusions: Adjunctive HBOT for DFU is cost-effective compared with standard care. Additional HBOT capacity would be needed if it were to be adopted as the standard of care throughout Canada. A concern is that evidence of clinical benefit remains limited, suggesting the need for good quality comparative studies under Canadian conditions.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Amputation
  • Canada
  • Cost-Benefit Analysis
  • Diabetic Foot
  • Humans
  • Hyperbaric Oxygenation
  • Prevalence
  • Quality-Adjusted Life Years
  • economics
  • surgery
  • hsrmtgs
UI: 103724770

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov